Dementias Platform UK
@dementiasplatform.bsky.social
Powering research to find new ways of detecting and treating #dementia. Providing infrastructure to enable research at scale and pace. Funded by #MedicalResearchCouncil. Based at Oxford University with teams at universities across the UK and in industry.
📚 340+ publications enabled or cited DPUK in the last 5 years
Our reach is broad. Our impact is real.
From data infrastructure to research collaborations - we're supporting discoveries that matter.
#DementiaResearch #ResearchImpact #DPUK
Our reach is broad. Our impact is real.
From data infrastructure to research collaborations - we're supporting discoveries that matter.
#DementiaResearch #ResearchImpact #DPUK
January 5, 2026 at 8:24 AM
📚 340+ publications enabled or cited DPUK in the last 5 years
Our reach is broad. Our impact is real.
From data infrastructure to research collaborations - we're supporting discoveries that matter.
#DementiaResearch #ResearchImpact #DPUK
Our reach is broad. Our impact is real.
From data infrastructure to research collaborations - we're supporting discoveries that matter.
#DementiaResearch #ResearchImpact #DPUK
🤖 NEW REPORT: AI in Sensitive Healthcare Data
Our data team @SwanseaUni with @DAREuk produced this vital report on unique challenges of complex multi-modal data in health research.
Download: zurl.co/qTFI0
#AI #HealthData #DPUK
Our data team @SwanseaUni with @DAREuk produced this vital report on unique challenges of complex multi-modal data in health research.
Download: zurl.co/qTFI0
#AI #HealthData #DPUK
January 4, 2026 at 8:38 AM
🤖 NEW REPORT: AI in Sensitive Healthcare Data
Our data team @SwanseaUni with @DAREuk produced this vital report on unique challenges of complex multi-modal data in health research.
Download: zurl.co/qTFI0
#AI #HealthData #DPUK
Our data team @SwanseaUni with @DAREuk produced this vital report on unique challenges of complex multi-modal data in health research.
Download: zurl.co/qTFI0
#AI #HealthData #DPUK
🧠 300,000+ neuroimaging scans on our Data Portal
Pre-loaded analysis tools. Growing all the time.
Researchers: Check our Imaging Matrix to see what's available 👇
zurl.co/Ww377
#Neuroimaging #DementiaResearch #DPUK
Pre-loaded analysis tools. Growing all the time.
Researchers: Check our Imaging Matrix to see what's available 👇
zurl.co/Ww377
#Neuroimaging #DementiaResearch #DPUK
January 2, 2026 at 10:36 AM
🧠 300,000+ neuroimaging scans on our Data Portal
Pre-loaded analysis tools. Growing all the time.
Researchers: Check our Imaging Matrix to see what's available 👇
zurl.co/Ww377
#Neuroimaging #DementiaResearch #DPUK
Pre-loaded analysis tools. Growing all the time.
Researchers: Check our Imaging Matrix to see what's available 👇
zurl.co/Ww377
#Neuroimaging #DementiaResearch #DPUK
🎯 72,000 people in our Trials Delivery Framework registers
Trial & study researchers can access Great Minds and CSR - pre-clinical dementia registers totalling 72,000 people.
Accelerating recruitment = accelerating discoveries.
#ClinicalTrials #DementiaResearch #DPUK
Trial & study researchers can access Great Minds and CSR - pre-clinical dementia registers totalling 72,000 people.
Accelerating recruitment = accelerating discoveries.
#ClinicalTrials #DementiaResearch #DPUK
December 30, 2025 at 8:20 AM
🎯 72,000 people in our Trials Delivery Framework registers
Trial & study researchers can access Great Minds and CSR - pre-clinical dementia registers totalling 72,000 people.
Accelerating recruitment = accelerating discoveries.
#ClinicalTrials #DementiaResearch #DPUK
Trial & study researchers can access Great Minds and CSR - pre-clinical dementia registers totalling 72,000 people.
Accelerating recruitment = accelerating discoveries.
#ClinicalTrials #DementiaResearch #DPUK
🎉 500 participants recruited to READ-OUT in its first year!
#DPUK blood biomarker study launched in January and already hit this incredible milestone.
Our volunteers are helping identify blood tests for dementia to roll out across the NHS. #DementiaResearch #Biomarkers
#DPUK blood biomarker study launched in January and already hit this incredible milestone.
Our volunteers are helping identify blood tests for dementia to roll out across the NHS. #DementiaResearch #Biomarkers
December 29, 2025 at 8:00 AM
🎉 500 participants recruited to READ-OUT in its first year!
#DPUK blood biomarker study launched in January and already hit this incredible milestone.
Our volunteers are helping identify blood tests for dementia to roll out across the NHS. #DementiaResearch #Biomarkers
#DPUK blood biomarker study launched in January and already hit this incredible milestone.
Our volunteers are helping identify blood tests for dementia to roll out across the NHS. #DementiaResearch #Biomarkers
🚀 2,000 recruits to our FAST study!
Assessing feasibility & accessibility of blood tests for dementia through data & samples from people over 50 - cognitively healthy or with MCI.
Building the evidence base for next-gen diagnostics.
#DementiaResearch #ClinicalTrials #DPUK
Assessing feasibility & accessibility of blood tests for dementia through data & samples from people over 50 - cognitively healthy or with MCI.
Building the evidence base for next-gen diagnostics.
#DementiaResearch #ClinicalTrials #DPUK
December 28, 2025 at 8:00 AM
🚀 2,000 recruits to our FAST study!
Assessing feasibility & accessibility of blood tests for dementia through data & samples from people over 50 - cognitively healthy or with MCI.
Building the evidence base for next-gen diagnostics.
#DementiaResearch #ClinicalTrials #DPUK
Assessing feasibility & accessibility of blood tests for dementia through data & samples from people over 50 - cognitively healthy or with MCI.
Building the evidence base for next-gen diagnostics.
#DementiaResearch #ClinicalTrials #DPUK
🌍 Find dementia data sources globally
Our searchable Data Landscape Report covers:
📊 Clinical Trials
🧠 Dementia Datasets
👥 Research Registers Worldwide.
Explore: zurl.co/2MWPR
#OpenData #DementiaResearch #DPUK
Our searchable Data Landscape Report covers:
📊 Clinical Trials
🧠 Dementia Datasets
👥 Research Registers Worldwide.
Explore: zurl.co/2MWPR
#OpenData #DementiaResearch #DPUK
December 27, 2025 at 8:36 AM
🌍 Find dementia data sources globally
Our searchable Data Landscape Report covers:
📊 Clinical Trials
🧠 Dementia Datasets
👥 Research Registers Worldwide.
Explore: zurl.co/2MWPR
#OpenData #DementiaResearch #DPUK
Our searchable Data Landscape Report covers:
📊 Clinical Trials
🧠 Dementia Datasets
👥 Research Registers Worldwide.
Explore: zurl.co/2MWPR
#OpenData #DementiaResearch #DPUK
🧠 13,500+ people on our Great Minds Register!
Highly characterised volunteers ready to join health studies and accelerate dementia research.
Want to make a difference? Join Great Minds 👇
zurl.co/4grwF
#DementiaResearch #GreatMinds #DPUK
Highly characterised volunteers ready to join health studies and accelerate dementia research.
Want to make a difference? Join Great Minds 👇
zurl.co/4grwF
#DementiaResearch #GreatMinds #DPUK
Welcome
zurl.co
December 24, 2025 at 8:39 AM
🧠 13,500+ people on our Great Minds Register!
Highly characterised volunteers ready to join health studies and accelerate dementia research.
Want to make a difference? Join Great Minds 👇
zurl.co/4grwF
#DementiaResearch #GreatMinds #DPUK
Highly characterised volunteers ready to join health studies and accelerate dementia research.
Want to make a difference? Join Great Minds 👇
zurl.co/4grwF
#DementiaResearch #GreatMinds #DPUK
📈 Delivering for dementia research!
15% increase in study applications for our Data Portal this year. More researchers = more discoveries.
(Except when COVID struck - we don't talk about that year 😉)
#DementiaResearch #OpenScience #DPUK
15% increase in study applications for our Data Portal this year. More researchers = more discoveries.
(Except when COVID struck - we don't talk about that year 😉)
#DementiaResearch #OpenScience #DPUK
December 23, 2025 at 10:26 AM
📈 Delivering for dementia research!
15% increase in study applications for our Data Portal this year. More researchers = more discoveries.
(Except when COVID struck - we don't talk about that year 😉)
#DementiaResearch #OpenScience #DPUK
15% increase in study applications for our Data Portal this year. More researchers = more discoveries.
(Except when COVID struck - we don't talk about that year 😉)
#DementiaResearch #OpenScience #DPUK
Digital cognitive remediation therapy #DCRT offers a scalable, accessible intervention for #MCI or #dementia, for settings with limited clinical resources. It compares with conventional #CRT. Long-term and functional impacts remain uncertain.
READ MORE zurl.co/cXSvy
READ MORE zurl.co/cXSvy
December 22, 2025 at 2:50 PM
Digital cognitive remediation therapy #DCRT offers a scalable, accessible intervention for #MCI or #dementia, for settings with limited clinical resources. It compares with conventional #CRT. Long-term and functional impacts remain uncertain.
READ MORE zurl.co/cXSvy
READ MORE zurl.co/cXSvy
Thanks Alex McCreadie (+ 499 others). He's our 500th recruit to our #READ-OUT study - evaluating tests diagnosing #dementia to use in the #NHS, for the Blood Biomarker Challenge run by @alzheimersresearchuk.org & @alzheimerssoc.bsky.social. Recruited by @ReMind_UK in Bath. #MCI #ageing #brainhealth
December 12, 2025 at 8:03 AM
What next for GLP-1 receptor agonists and dementia?
So, semaglutide didn't slow cognitive decline in early Alzheimer's, but there were positive outcomes. Read Ivan Koychev's reflections. zurl.co/PaL1s
#DementiaResearch #AlzheimersResearch #ClinicalTrials #Prevention #DPUK #GLP1
So, semaglutide didn't slow cognitive decline in early Alzheimer's, but there were positive outcomes. Read Ivan Koychev's reflections. zurl.co/PaL1s
#DementiaResearch #AlzheimersResearch #ClinicalTrials #Prevention #DPUK #GLP1
What next for GLP-1 receptor agonists and dementia?
Novo Nordisk's EVOKE trial didn't meet its primary endpoint - semaglutide didn't slow cognitive decline in people with early Alzheimer's. But the results revealed something intriguing: reductions in biomarkers of neurodegeneration, inflammation, and tau protein. The drug does something to Alzheimer's biology - the question is when to use it.
zurl.co
December 9, 2025 at 10:35 AM
What next for GLP-1 receptor agonists and dementia?
So, semaglutide didn't slow cognitive decline in early Alzheimer's, but there were positive outcomes. Read Ivan Koychev's reflections. zurl.co/PaL1s
#DementiaResearch #AlzheimersResearch #ClinicalTrials #Prevention #DPUK #GLP1
So, semaglutide didn't slow cognitive decline in early Alzheimer's, but there were positive outcomes. Read Ivan Koychev's reflections. zurl.co/PaL1s
#DementiaResearch #AlzheimersResearch #ClinicalTrials #Prevention #DPUK #GLP1
#DPUK has groundbreaking #dementia studies in our Experimental Medicine Incubator. We’re running 7 randomised trials and 31 observational studies.
Our work could be key to better treatment in future." – Prof. James Rowe, Cambridge University
Read more zurl.co/iVIQS
Our work could be key to better treatment in future." – Prof. James Rowe, Cambridge University
Read more zurl.co/iVIQS
December 4, 2025 at 4:06 PM
#DPUK has groundbreaking #dementia studies in our Experimental Medicine Incubator. We’re running 7 randomised trials and 31 observational studies.
Our work could be key to better treatment in future." – Prof. James Rowe, Cambridge University
Read more zurl.co/iVIQS
Our work could be key to better treatment in future." – Prof. James Rowe, Cambridge University
Read more zurl.co/iVIQS
Dementia is now the UK's most feared illness, reports @Telegraph. At #DPUK, we understand the urgency. We're accelerating research by connecting scientists with crucial data to develop better treatments. Together, we can change the future. zurl.co/st2Ee #BrainHealth
December 2, 2025 at 8:30 AM
Dementia is now the UK's most feared illness, reports @Telegraph. At #DPUK, we understand the urgency. We're accelerating research by connecting scientists with crucial data to develop better treatments. Together, we can change the future. zurl.co/st2Ee #BrainHealth
🧠 What happens inside our brains as we age?
Researcher Fatemeh (Simeen) Tabassi Mofrad analysed 46,000+ MRI scans to map brain ageing—revealing why some regions are more vulnerable than others.
Discover the findings 👉 zurl.co/AAoSv
#DementiaResearch #BrainHealth #UKBiobank
Researcher Fatemeh (Simeen) Tabassi Mofrad analysed 46,000+ MRI scans to map brain ageing—revealing why some regions are more vulnerable than others.
Discover the findings 👉 zurl.co/AAoSv
#DementiaResearch #BrainHealth #UKBiobank
Charting the Ageing Brain: Insights from 46,000 MRI Scans
What happens inside our brains as we age? Researcher Fatemeh (Simeen) Tabassi Mofrad used UK Biobank data to create an unprecedented map of brain ageing—and discovered why some regions are more vulnerable than others.
zurl.co
December 1, 2025 at 10:35 AM
🧠 What happens inside our brains as we age?
Researcher Fatemeh (Simeen) Tabassi Mofrad analysed 46,000+ MRI scans to map brain ageing—revealing why some regions are more vulnerable than others.
Discover the findings 👉 zurl.co/AAoSv
#DementiaResearch #BrainHealth #UKBiobank
Researcher Fatemeh (Simeen) Tabassi Mofrad analysed 46,000+ MRI scans to map brain ageing—revealing why some regions are more vulnerable than others.
Discover the findings 👉 zurl.co/AAoSv
#DementiaResearch #BrainHealth #UKBiobank
Thrilled that biomarker pilot project, delivered with Eli Lilly & Company and 4 NHS trusts, has won the prestigious @HSJ_Awards Partnership of the Year Award 2025! The project aims to transform early diagnosis of #Alzheimer’s disease by testing the scalability of biomarker diagnostics.
November 21, 2025 at 11:33 AM
Thrilled that biomarker pilot project, delivered with Eli Lilly & Company and 4 NHS trusts, has won the prestigious @HSJ_Awards Partnership of the Year Award 2025! The project aims to transform early diagnosis of #Alzheimer’s disease by testing the scalability of biomarker diagnostics.
We’re thrilled our cross-sector project to improve Alzheimer’s diagnosis, a partnership between Dementias Platform UK , Eli Lilly UK & Ireland, and four NHS Trusts, has been shortlisted for the 2025 HSJ Partnership of the Year Award, recognising healthcare innovation in the UK.
November 17, 2025 at 8:15 AM
We’re thrilled our cross-sector project to improve Alzheimer’s diagnosis, a partnership between Dementias Platform UK , Eli Lilly UK & Ireland, and four NHS Trusts, has been shortlisted for the 2025 HSJ Partnership of the Year Award, recognising healthcare innovation in the UK.
Happy Friday! 🎉
Weekend plans? New research shows just 3,000 steps a day (30 min walk) could cut Alzheimer's risk by nearly half 🧠👟
Optimal: 5,000-7,500 steps. Get outside, grab a friend, enjoy nature.
Every step counts!
zurl.co/gSyQy
#HappyFriday #BrainHealth
Weekend plans? New research shows just 3,000 steps a day (30 min walk) could cut Alzheimer's risk by nearly half 🧠👟
Optimal: 5,000-7,500 steps. Get outside, grab a friend, enjoy nature.
Every step counts!
zurl.co/gSyQy
#HappyFriday #BrainHealth
Even a few thousand steps a day can reduce your risk of Alzheimer’s – new study
Even modest amounts of walking – as few as 3,000 steps a day – may help protect against Alzheimer’s by reducing harmful tau proteins in the brain.
zurl.co
November 14, 2025 at 9:15 AM
Happy Friday! 🎉
Weekend plans? New research shows just 3,000 steps a day (30 min walk) could cut Alzheimer's risk by nearly half 🧠👟
Optimal: 5,000-7,500 steps. Get outside, grab a friend, enjoy nature.
Every step counts!
zurl.co/gSyQy
#HappyFriday #BrainHealth
Weekend plans? New research shows just 3,000 steps a day (30 min walk) could cut Alzheimer's risk by nearly half 🧠👟
Optimal: 5,000-7,500 steps. Get outside, grab a friend, enjoy nature.
Every step counts!
zurl.co/gSyQy
#HappyFriday #BrainHealth
New Paper from @dementiasplatform.bsky.social researchers FatemehTabassi Mofrad and Chris Patrick Pflanz. Their findings offer a guide for regenerative strategies and therapeutic interventions by locating subcortical regions most vulnerable to age-related atrophy and inflammation.
zurl.co/HEjQM
zurl.co/HEjQM
November 13, 2025 at 11:42 AM
New Paper from @dementiasplatform.bsky.social researchers FatemehTabassi Mofrad and Chris Patrick Pflanz. Their findings offer a guide for regenerative strategies and therapeutic interventions by locating subcortical regions most vulnerable to age-related atrophy and inflammation.
zurl.co/HEjQM
zurl.co/HEjQM
Congratulations to Dishaa Sinha, one of the many outstanding women working with @dementiasplatform.bsky.social for her award at #WINAwards2025. She has done great work on our #FAST study and #GreatMinds register. #dementiaresearch #cognition #bloodbiomarkers #ageing #aging 👏👩🔬
She currently completes her PhD on speech-based biomarkers of dementia — demonstrating exceptional determination while building inclusive dementia research. 🧠💙
Award supported by @kingsioppn.bsky.social 💙
Award supported by @kingsioppn.bsky.social 💙
November 10, 2025 at 11:09 AM
Congratulations to Dishaa Sinha, one of the many outstanding women working with @dementiasplatform.bsky.social for her award at #WINAwards2025. She has done great work on our #FAST study and #GreatMinds register. #dementiaresearch #cognition #bloodbiomarkers #ageing #aging 👏👩🔬
Reposted by Dementias Platform UK
Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease www.nature.com/articles/s41...
Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease - Nature Medicine
In cognitively normal older adults at risk for Alzheimer’s dementia, physical inactivity was associated with faster tau protein buildup and cognitive decline.
www.nature.com
November 7, 2025 at 2:26 PM
Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease www.nature.com/articles/s41...
🔊STUDENTSHIPS
There's less than a month left to apply for our studentship opportunities: buff.ly/oAwC7FG
Deadline: 2 December 2025.
There's less than a month left to apply for our studentship opportunities: buff.ly/oAwC7FG
Deadline: 2 December 2025.
November 7, 2025 at 2:30 PM
Great to see READ-OUT study and the #BloodBiomarkerChallenge leading the news on Points West zurl.co/Sg16V
Both @researchnbt.bsky.social and
@reminduk.bsky.social are participating in the study. It could revolutionise #dementia #diagnosis @alzheimerssoc.bsky.social @alzheimersresearchuk.org
Both @researchnbt.bsky.social and
@reminduk.bsky.social are participating in the study. It could revolutionise #dementia #diagnosis @alzheimerssoc.bsky.social @alzheimersresearchuk.org
Points West - Evening News: 04/11/2025
The latest news, sport, weather and features from the West of England.
zurl.co
November 5, 2025 at 10:08 AM
Great to see READ-OUT study and the #BloodBiomarkerChallenge leading the news on Points West zurl.co/Sg16V
Both @researchnbt.bsky.social and
@reminduk.bsky.social are participating in the study. It could revolutionise #dementia #diagnosis @alzheimerssoc.bsky.social @alzheimersresearchuk.org
Both @researchnbt.bsky.social and
@reminduk.bsky.social are participating in the study. It could revolutionise #dementia #diagnosis @alzheimerssoc.bsky.social @alzheimersresearchuk.org
Dr Delia Gheorghe & Prof Sarah Bauermeister discussed their @DementiasUK research on Pro TV News Romania (interview in Romanian).
Great to see dementia research reaching international audiences!
👉 Watch the interview: zurl.co/QHi9d
#DementiaResearch #SciComm
Great to see dementia research reaching international audiences!
👉 Watch the interview: zurl.co/QHi9d
#DementiaResearch #SciComm
November 4, 2025 at 8:19 AM
Dr Delia Gheorghe & Prof Sarah Bauermeister discussed their @DementiasUK research on Pro TV News Romania (interview in Romanian).
Great to see dementia research reaching international audiences!
👉 Watch the interview: zurl.co/QHi9d
#DementiaResearch #SciComm
Great to see dementia research reaching international audiences!
👉 Watch the interview: zurl.co/QHi9d
#DementiaResearch #SciComm
A fantastic new milestone for the @dpukdataportal.bsky.social which has passed last year's record access requests - hitting 150 so far in 2025. AND we've had over 2,500 dataset requests too. Continued growth for an extraordinary #dementia #research resource. #aging #cognition
October 27, 2025 at 11:28 AM
A fantastic new milestone for the @dpukdataportal.bsky.social which has passed last year's record access requests - hitting 150 so far in 2025. AND we've had over 2,500 dataset requests too. Continued growth for an extraordinary #dementia #research resource. #aging #cognition